Cargando…
Src kinase inhibitor PP2 regulates the biological characteristics of A549 cells via the PI3K/Akt signaling pathway
Lung cancer is one of the most prevalent types of cancer worldwide, with a poor prognosis for patients and a concomitant financial burden on society. There are a number of different pathological subtypes, with non-small cell lung cancer (NSCLC) being the primary subtype. Although anticancer therapy...
Autores principales: | Dai, Xi, Wang, Li-Jiao, Wu, Juan, Shi, Ya-Xu, Li, Guo-Ping, Yang, Xiao-Qiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144924/ https://www.ncbi.nlm.nih.gov/pubmed/30250573 http://dx.doi.org/10.3892/ol.2018.9282 |
Ejemplares similares
-
Effect of BRAF-mediated PI3K/Akt/mTOR pathway on biological characteristics and chemosensitivity of NSCLC A549/DDP cells
por: Ren, Bingnan, et al.
Publicado: (2021) -
Inhibition of Oncogenic Src Ameliorates Silica-Induced Pulmonary Fibrosis via PI3K/AKT Pathway
por: Hao, Xiaohui, et al.
Publicado: (2023) -
Tumor-associated macrophages affect the biological behavior of lung adenocarcinoma A549 cells through the PI3K/AKT signaling pathway
por: Yuan, Shiyang, et al.
Publicado: (2019) -
$pp^{-}$ annihilation into $K^{+}K^{-}$ and $\pi^{+}\pi^{-}$
por: Witzig, Christoph
Publicado: (1991) -
GZD824 suppresses the growth of human B cell precursor acute lymphoblastic leukemia cells by inhibiting the SRC kinase and PI3K/AKT pathways
por: Ye, Wei, et al.
Publicado: (2016)